Ownership history in Man Group plc · 12 quarters on record
This page tracks every 13F SEC filing in which Man Group plc reported a position in TRAVERE THERAPEUTICS INC (TVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 29,727 | -109,317 | -78.6% | 0.00% | $710K | $23.90 |
| 2025 Q2 | ADDED | 139,044 | +90,265 | +185.0% | 0.00% | $2.1M | $14.80 |
| 2025 Q1 | REDUCED | 48,779 | -39,462 | -44.7% | 0.00% | $874K | $17.92 |
| 2024 Q4 | ADDED | 88,241 | +62,798 | +246.8% | 0.00% | $1.5M | $17.42 |
| 2024 Q3 | REDUCED | 25,443 | -73,219 | -74.2% | 0.00% | $356K | $13.99 |
| 2024 Q2 | REDUCED | 98,662 | -18,939 | -16.1% | 0.00% | $811K | $8.22 |
| 2024 Q1 | ADDED | 117,601 | +99,101 | +535.7% | 0.00% | $907K | $7.71 |
| 2023 Q1 | REDUCED | 18,500 | -2,800 | -13.1% | 0.00% | $416K | $22.49 |
| 2022 Q4 | ADDED | 21,300 | +2,800 | +15.1% | 0.00% | $448K | $21.03 |
| 2022 Q3 | ADDED | 18,500 | +9,000 | +94.7% | 0.00% | $456K | $24.64 |
As of 2025 Q4 — sorted by position size